Cleveland Clinic Chair Robert Rich Wants to Focus on Patient Quality

Advertisement

Robert E. Rich Jr., the succeeding chairman of Cleveland Clinic’s board of directors, says he wants to bring the Clinic’s quality and patient safety standards and procedures to the forefront of the agenda, according to a Plain Dealer report.

Mr. Rich, 70, will assume his position as chairman in March when the board convenes, replacing A. Malachi Mixon, III, who stepped down in December. Mr. Rich is the chairman of Rich Products, his family-owned food company which also happens to be the country’s largest frozen foods manufacturer, selling more than 2,000 products. He now resides in Florida.

Mr. Rich, who is a current or former member of nearly 20 boards, says he hopes the Clinic board first tackles committee structures as well. “The best boards I’ve served on have been the most active and effectively engaged committees,” Mr. Rich said in the report. Other focuses include succession planning and strengthening relations with community hospitals.

In the article, Mr. Rich also said he plans to go deeper on some issues than Mr. Mixon did. “Community is very important to me,” says Mr. Rich. “I think that’s something that I’ll get personally involved in a little more.”

Read the Plain Dealer report on Cleveland Clinic chair Robert E. Rich.

Read more about Cleveland Clinic:

– Cleveland Clinic to Help Hospital System Market Medical Inventions

– Cleveland Clinic CEO Credited With Idea of City’s New Medical Mart

– Cleveland Clinic Partners With Pennsylvania Hospital for Stroke Care

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Patient Experience

Advertisement

Comments are closed.